...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: Re: Future Trials
5
Feb 14, 2020 02:12AM
2
Feb 14, 2020 09:18AM
2
Feb 14, 2020 09:39AM
4
Feb 14, 2020 10:02AM
3
Feb 14, 2020 10:07AM
2
Feb 14, 2020 11:20AM
2
Feb 14, 2020 01:36PM
7
Feb 14, 2020 02:40PM

BDZ - I know of one drug that was approved by FDA for prevention of CHF in diabetics on the basis of a secondary endpoint in P3 trial. So there is hope.

2
Feb 14, 2020 03:32PM
Share
New Message
Please login to post a reply